Exchange: OTC·Updated 10:40 AM EDT

PGABF Prostatype Genomics AB

$0.1342
$0.0492
(57.88%)
Today
Mkt Cap$71.49M
Vol100.00

About PGABF

Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. It helps clinicians and patients to make correct treatment decisions. The company was founded in 2007 and is headquartered in Nacka, Sweden.
86

Extremely Bullish Sentiment

How do you feel about PGABF?

Advertisement|Remove ads.